# Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma

> **NCT05752136** · PHASE3 · RECRUITING · sponsor: **Sir Run Run Shaw Hospital** · enrollment: 108 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **BIOLOGICAL:** Envafolimab

## Key facts

- **NCT ID:** NCT05752136
- **Lead sponsor:** Sir Run Run Shaw Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2025-04
- **Final completion:** 2028-12
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2023-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05752136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05752136, "Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05752136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*